Latest filing published 18 Sept 2017 for Rocket Pharmaceuticals, INC..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -80.9%Entry US$134.55 · Close at T+365 US$25.65
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Dale Ritter: trading record in brief
Dale Ritter has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Indevus Pharmaceuticals Inc, Fortress Biotech, Inc. and Rocket Pharmaceuticals, Inc. In total, 6 filings cover trades dated from 31 March 2006 to 14 September 2017.
The open-market record is one-sided, with 2 purchases worth €24k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 3 share grants and 1 option exercise.
The latest filing, published on 18 September 2017, reports an option exercise in Rocket Pharmaceuticals, Inc. The most recent open-market purchase was published on 4 June 2013, 4,906 days ago. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Dale Ritter
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 12,500 shares0Common StockSEC:0001209191-17-053158:0
- 1,503 shares@ US$3.88Common Stock, par value $0.001SEC:0001181431-13-032501:0Canonical exit: 29 Aug 2013 (T+90)
- 1,319 shares@ US$2.85Common Stock, $.001 par valueSEC:0001181431-08-055679:0
- 398 shares@ US$5.03Common Stock, $.001 par valueSEC:0001181431-06-056341:0
- 7,258 shares@ US$2.37Common Stock, $.001 par valueSEC:0001181431-06-021994:0
5 of 5 declarations
